December 2008
Worldwide Biotech;Dec2008, Vol. 20 Issue 12, p8
Trade Publication
The article reports on the patent grants received by InNexus Biotechnology Inc. in several countries in Europe which further expanded the patent protections of its DXL technology in Europe. The patents are titled Method of Affinity Cross-Linking Biologically Active, Immunogenic Peptides to Antibodies.


Related Articles

  • European patents for DXL technology.  // Medical Device Daily;10/31/2008, Vol. 12 Issue 213, p8 

    The article reports that patent grants were given to InNexus Biotechnology for its next generation of monoclonal antibodies using its Dynamic Cross Linking (DXL) technology. The patents titled "Method of Affinity Cross-Linking Biologically Active, Immunogenic Peptides to Antibodies" were granted...

  • German länder leave tech transfer agency.  // Outlook on Science Policy;Jan2004, Vol. 26 Issue 1, p6 

    Reports on the German government's decision to extend the funding program to support regional patent and commercialization agencies (PCA). Aim to provide professional services to universities and non-university research institutes; Highlights of their activities; Expectation of funding from the...

  • Disputes, grants, communications.  // Industrial Physicist;Apr/May2002, Vol. 8 Issue 2, p33 

    Answers questions from readers on disputes, grants and communications in work. Arbitration of customers in disputes; Limits to the use of customer information from a bankrupt online company; Filing of a patent application before contact with potential investors.

  • InNexus Biotechnology Files Patent for Novel AMD Therapeutic.  // Biomedical Market Newsletter;6/19/2011, p546 

    The article reports that biopharmaceutical company Innexus Biotechnology Inc. has filed for patent protection regarding its Age-related Macular Degeneration (AMD) and eye disorder antibody product. It mentions that the product of the company was develop as topical therapy or eye drop for several...

  • LETTERS to the EDITOR. Crain, Orville V.; Glaser, Otto; Davis, Henry // Inventors' Digest;Apr-Jun2006, Vol. 22 Issue 2, p4 

    Presents letters to the editor about the "Inventors' Digest" magazine, the Patent Act of 2005 and the Balance Oasis Grants.

  • No go in nano. Kinsler, Maureen // Electronics Weekly;11/8/2006, Issue 2264, p24 

    The article discusses the small number of European intellectual property patents in nanotechnology, compared to the U.S., despite a huge amount of funding in Europe. The rate of patent filing is alarmingly low in Europe. It was believed that nanotechnology will revolutionise the electronics...

  • Changes to the EMDG scheme.  // Australian & New Zealand Grapegrower & Winemaker;2008, Issue 535, p115 

    The article outlines key changes made to the Export Market Development Grants (EMDG) scheme in Australia. They include allowing costs of patenting products overseas to be eligible for EMDG support, lifting the maximum turnover limit from $30 million to $50 million and making the scheme more...

  • LETTERS. Gleave, Stephen; Greenwood, Jim; Sage, Richard; Cearns, Kathryn; Morgan, Gareth G.; Franklin, R. C.; Knights, K. W. // Accountancy;Jul2001, Vol. 128 Issue 1295, p31 

    Presents letters to the editor referencing articles and topics discussed in previous issues related to accounting. "Divided We Stand," by Heidi Whettingsteel, which presented an argument on the nature of patents; Opinion on duvet days; Query about handling grants and depreciation in charity...

  • Sensaphonics 3D Active Ambient IEM System gains US patent. Kontney, Jack // Broadcast Engineering Exclusive Insight;1/20/2012, p12 

    The article reports on the decision of the U.S. Patent and Trademark Office to grant a patent for the 3D Active Ambient IEM System to Sensaphonics in January 2012. Fifty specific claims for the three-dimensional (3-D) system were included in the patent application. Sensaphonics founder Michael...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics